Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-03-06 @ 9:34 AM
Study NCT ID:
NCT06176534
Status:
RECRUITING
Last Update Posted:
2024-08-20
First Post:
2023-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial
Sponsor:
Henan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-20
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-09
First Submit QC Date:
None
Study First Post Date:
2023-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-19
Last Update Post Date:
2024-08-20
Last Update Post Date Type:
ACTUAL